Press Releases with tag "GeoVax"



GeoVax Trial Results Establish a New Benchmark for Preventative HIV Vaccine Model i-Newswire, 2011-06-08
Non Human Primate Study Demonstrates Unprecedented 70% Prevention of Infection

GeoVax Launches Second Clinical Site To Test The Therapeutic Benefit of HIV Vaccine i-Newswire, 2011-02-09
University of Alabama at Birmingham to Serve as Second Site for Ongoing Clinical Trial

GeoVax Awarded Federal Grant Under The Qualifying Therapeutic Discovery Project Program i-Newswire, 2010-11-04
The grant was awarded following GeoVax’s submission for consideration of its HIV/AIDS vaccine research and development project to the U.S. Secretary of Health and Human Services.

One Company Aims to Repurpose a Smallpox Vaccine to Battle HIV i-Newswire, 2010-08-23
Because of the difficulty raising antibodies that are capable of totally blocking natural HIV infections, the GeoVax vaccine approach has focused on raising cellular immune responses in addition to antibodies.

GeoVax Labs, Inc. Announces Six Month 2010 Financial Results and Provides Operational Update i-Newswire, 2010-08-05
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm (the "Company") developing vaccines that prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced its financial results and provided an update.

Newly Discovered Antibodies May Boost AIDS Vaccine Research i-Newswire, 2010-07-13
GeoVax is developing a vaccine that presents the natural form of HIV envelope proteins to the immune system on virus-like particles with the envelope proteins present in clusters of three, a confirmation known as trimers.

Early Diagnosis and Treatment for HIV Has Life-Saving Impact on Patients i-Newswire, 2010-06-22
Since 1995, National HIV Testing Day has united organizations across the nation every June 27th to promote the early diagnosis of HIV.



© Copyright 2012 I-Newswire.com - press release distribution service. All rights reserved